Showing results (11-20 of 191) with videos related to
Sort By:
Pageof 20
Current Drug Safety|August 12, 2008
Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosisMark A PerazellaClinical Journal of the American Society of Nephrology : CJASN|February 10, 2009
Current status of gadolinium toxicity in patients with kidney diseaseMark A PerazellaClinical Journal of the American Society of Nephrology : CJASN|June 13, 2009
Renal vulnerability to drug toxicityMark A PerazellaClinical Nephrology|April 3, 2014
Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinicianMark A PerazellaAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2015
The urine sediment as a biomarker of kidney diseaseMark A PerazellaExpert Opinion on Drug Safety|August 9, 2003
COX-2 selective inhibitors: analysis of the renal effectsMark A PerazellaCurrent Opinion in Nephrology and Hypertension|July 23, 2009
Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect stormMark A PerazellaClinical Journal of the American Society of Nephrology : CJASN|October 27, 2012
AKI in a hospitalized patient with cellulitisMark A PerazellaClinical Journal of the American Society of Nephrology : CJASN|August 11, 2012
Onco-nephrology: renal toxicities of chemotherapeutic agentsMark A PerazellaAdvances in Chronic Kidney Disease|March 13, 2017
Clinical Approach to Diagnosing Acute and Chronic Tubulointerstitial DiseaseMark A PerazellaPageof 20